Life Sciences and Healthcare
Lifang & Partners is a leading full-service law firm specializing in the life sciences and healthcare sector in China. We cater to a diverse clientele including pharmaceutical companies, medical device companies, hospitals, industry associations, private equity funds, and venture capital businesses. Our firm is dedicated to staying up-to-date with legal and commercial advancements in the pharmaceutical industry, ensuring that we provide efficient and practical solutions for our clients. Our team of experts in the life sciences and healthcare field boasts extensive experience in various areas such as mergers and acquisitions, capital markets, private equity and venture capital investments, intellectual property, compliance, and dispute resolution. Many of our professionals have previously worked for prominent pharmaceutical companies and regulatory authorities. By combining our past legal expertise with a comprehensive understanding of the current industry landscape, we empower our clients to attain their business goals.
Our legal services in this field cover:
IP: Patent Prosecution/Invalidation, Patent Portfolio, FTO, IP Licensing and Transfer, Trademark/Copyright Registration, Trademark/Copyright Invalidation, Brand Protection, Trade Secret Protection, IP Litigation
Compliance and Regulatory: GxP Compliance, R&D/Clinical Trials, Market Entry, Product Promotion Activities, Compliance with Bribery Regulation, Healthcare Data Protection, Human Genetic Resources Regulation
Antitrust and unfair competition: Antitrust Compliance Counseling, Antitrust Compliance System Building , Merger Controls, Antitrust Investigations, Antitrust Litigation
Capital Markets: Employee Incentive, Domestic and Overseas IPOs, Corporate Governance and Structuring, General Legal Counseling Service
Mergers, Acquisitions, Reorganization: Mergers and Acquisitions, Joint Ventures and Collaborations, Post-IPO Asset Restructuring, Debt Restructuring, Corporate Bankruptcy
Notable Cases
Representing a global biotechnology giant in a series of drug patent linkage actions against generic drug companies
Midday v. Aonuo
Chongqing Zhengtong v. Sichuan Huashu Animal Pharmaceutical Co Ltd.
Representing a global pharmaceutical company in a series of patent administrative lawsuits
Hua Yuqiang v. Shuangding Pharmaceutical Co Ltd.
Novartis v. GSK
Jiangsu Wangao Pharmaceutical Co Ltd v. PRB and the Third-party Chengdu Youta Pharmaceutical Co Ltd
Providing patent analysis and prosecution services to a listed pharmaceutical company for its oncology kit project in China, the United States and Europe.
Providing year-round patent prosecution regarding communication standards for world-famous listed Internet company, including China and PCT applications
Antitrust compliance for a pharmaceutical company
Medical device compliance for an American technology company
Antitrust compliance for a pharmaceutical company
Medical device compliance for an American technology company
Medical device compliance for an American technology company
Changchun BCHT Biotechnology Co. for a listing on the Science and Technology Innovation Board
InTec for an IPO on the Growth Enterprises Market
Sanbo Brain for an IPO on the Growth Enterprises Market
Canwell Medical for a listing on the Science and Technology Innovation Board
Tasly Pharma for a listing on the Science and Technology Innovation Board
Bluesail Medical Co Ltd for a second phase issuance of bonds
General Legal Counsel Service for EN HUA YI YAO
General Legal Counsel Service for Shenzhen Xcision Medical Company
Representing a start-up biopharma company on acquiring new drug technology.
Providing opinions on IP strategy of a pharmaceutical project for Shanghai Chengwei Changqing Equity Investment Management Company
Advising a European pharma company on technology transaction dispute with a Chinese company, including litigation strategy related to trade secret infringement, IP ownership dispute and HKIAC Arbitration
Representing Immorna on R&D collaboration negotiations for mRNA vaccine development and drafting the agreement
Representing an innovative pharmaceutical company in Suzhou on technology collaboration with universities or other enterprises, and providing legal counseling and agreement drafting